Related Experiment Video
Updated: Aug 11, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
Tumours and tremors: how PTEN regulation underlies both
1Campbell Family Institute for Breast Cancer Research, 620 University Avenue, Toronto, Ontario M5G 2C1, Canada.
Abstract:
Mutations of the tumour suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) are seen in many human cancers. However, dysregulation of PTEN may be involved in other disease states such as Parkinson's disease. This minireview describes recent work examining PTEN regulation and its implications for the development of both cancer and neurodegenerative disease.
Insights
Tumour suppressor PTEN (phosphatase and tensin homolog deleted on chromosome 10) mutations are linked to cancer. Recent research explores PTEN regulation
Area of Science:
- Oncology
- Neuroscience
- Molecular Biology
Background:
- PTEN (phosphatase and tensin homolog deleted on chromosome 10) is a critical tumour suppressor.
- PTEN mutations are prevalent in various human cancers.
- Emerging evidence suggests PTEN dysregulation in neurodegenerative diseases like Parkinson's disease.
Purpose of the Study:
- To review recent advancements in understanding PTEN regulation.
- To explore the dual role of PTEN in both cancer and neurodegenerative disease pathogenesis.
- To highlight potential therapeutic implications of PTEN modulation.
Main Methods:
- Literature review of recent studies on PTEN.
- Analysis of molecular mechanisms underlying PTEN regulation.
- Synthesis of findings linking PTEN to cancer and neurodegeneration.
Main Results:
- PTEN plays a complex role in cellular processes beyond tumour suppression.
- Dysregulation of PTEN pathways contributes to the development of neurodegenerative conditions.
- Understanding PTEN regulation offers insights into novel therapeutic strategies.
Conclusions:
- PTEN is a key player in both oncogenesis and neurodegeneration.
- Targeting PTEN pathways may offer a unified approach for treating diverse diseases.
- Further research into PTEN regulation is crucial for clinical applications.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Neural Regulation
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
